Akari Therapeutics, Plc AKTX

$ 1.47 -6.37%

Quarterly report 2024-Q3
added 11-19-2024

Akari Therapeutics, Plc Financial Statements 2011-2024 | AKTX

Annual Financial Statements Akari Therapeutics, Plc

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	76.8 M	39.6 M	60.4 M	6.44 B	5.84 B	3.2 B	2.42 B	5.4 B	8.01 B	11.8 B	31.4 M	21.5 M	-	-
Shares	23.1 M	21.2 M	17.7 M	4.29 B	3.16 B	1.83 B	1.54 B	1.25 B	1.18 B	852 M	541 K	211 K	-	-
Historical Prices	3.32	1.87	3.41	1.5	1.85	1.75	1.57	4.33	7.04	14.5	48	-	-	-
Net Income	-2.08 M	-12.8 M	-13.1 M	-17.4 M	-17.1 M	-16.8 M	-16.5 M	-35.4 M	-18.1 M	-45.3 M	-9.65 M	-3.62 M	-1.44 M	-2.12 M
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-1.39 M	-13.1 M	-11.8 M	-17.2 M	-18 M	-17 M	-20 M	-37.8 M	-27.2 M	-30.6 M	-1.92 M	-3.61 M	-3.67 M	-2.25 M
Interest Expense	11	45.9 K	368 K	-	-	-	-	-	-	3.05 M	5.44 K	-14 K	-601 K	128 K
EBITDA	-	-13.1 M	-11.8 M	-17.2 M	-18 M	-16.9 M	-20 M	-37.7 M	-27.2 M	-53.5 M	-10.2 M	-3.65 M	-1.75 M	-2.38 M
Operating Expenses	-	-	-	17.2 M	-	17 M	22.7 M	35.1 M	27.2 M	11.3 M	-	-	-	-
General and Administrative Expenses	-	11.4 M	13.5 M	8.08 M	9.16 M	8.22 M	10.9 M	11.8 M	9.94 M	5.5 M	3.76 M	2.33 M	734 K	1.41 M

All numbers in USD currency

Quarterly Income Statement Akari Therapeutics, Plc

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	24.4 B	18.8 B	13.5 B	13.2 B	10.1 B	10.1 B	7.47 B	-	-	-	-	3.85 B	-	3.85 B	-	3.85 B	3.39 B	3 B	2.52 B	2.25 B	1.97 B	1.61 B	1.58 B	312 K	-	1.53 B	-	1.53 B	-	1.18 B	-	1.18 B	-	1.18 B	1.18 B	1.18 B	782 M	722 M	722 M	722 M	73.4 M	55.6 M	49.5 M	40.2 M	-	-	-	13.4 M	-	-	-	12.1 M	-	-	-
Net Income	-2.9 M	-7.56 M	-5.57 M	-	-2.87 M	-4 M	1 M	-	-	-	-	-	-	-4.35 M	-	-	913 K	-7.44 M	-3.75 M	-	-2.88 M	-5.95 M	-187 K	-	-	-8.02 M	-	-	-	-320 K	-	-	-	-6.45 M	-2.99 M	-	-48.7 M	-1.34 M	-1.7 M	-	-223 K	-2.23 M	-9.65 M	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-2.93 M	-7.45 M	-5.99 M	-	-2.51 M	-4.62 M	-4.59 M	-	-	-	-	-	-	-4.33 M	-	-	-247 K	-5.91 M	-4.93 M	-	-3.12 M	-6.03 M	12 K	-	-	-7.98 M	-	-	-	-7.35 M	-	-	-	-7.52 M	-3.85 M	-	-23.3 M	-1.31 M	-1.65 M	-	-218 K	-2.33 M	-1.88 M	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	51 K	-2 K	-	-22 K	-13 K	-11 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.05 M	2.61 K	4.56 K	-	2.88 K	101 K	143 K	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-5.98 M	-	-	-	-4.59 M	-	-	-	-	-	-	-4.33 M	-	-	-247 K	-5.91 M	-4.92 M	-	-3.12 M	-6.03 M	17.5 K	-	-	-7.97 M	-	-	-	-7.34 M	-	-	-	-7.51 M	-3.84 M	-	-23.3 M	-1.31 M	-1.65 M	-	-217 K	-2.33 M	-1.88 M	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	4.33 M	-	-	247 K	5.91 M	4.93 M	-	3.12 M	6.03 M	-12 K	-	-	7.98 M	-	-	-	7.35 M	-	-	-	7.52 M	3.85 M	-	23.3 M	1.31 M	1.65 M	-	218 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.71 M	2.24 M	3.71 M	-	2.82 M	3.09 M	2.86 M	-	-	-	-	-	-	2.15 M	-	-	1.84 M	2.89 M	2.19 M	-	1.35 M	2.44 M	2.31 M	-	-	2.86 M	-	-	-	3.57 M	-	-	-	2.08 M	2.35 M	-	2.73 M	311 K	99.7 K	-	55.5 K	56 K	56 K	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency